Cargando…
A Pragmatic Approach to Adverse Outcome Pathway Development and Evaluation
The adverse outcome pathway (AOP) framework provides a practical means for organizing scientific knowledge that can be used to infer cause-effect relationships between stressor events and toxicity outcomes in intact organisms. It has reached wide acceptance as a tool to aid chemical safety assessmen...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633887/ https://www.ncbi.nlm.nih.gov/pubmed/34534351 http://dx.doi.org/10.1093/toxsci/kfab113 |
_version_ | 1784608020247871488 |
---|---|
author | Svingen, Terje Villeneuve, Daniel L Knapen, Dries Panagiotou, Eleftheria Maria Draskau, Monica Kam Damdimopoulou, Pauliina O’Brien, Jason M |
author_facet | Svingen, Terje Villeneuve, Daniel L Knapen, Dries Panagiotou, Eleftheria Maria Draskau, Monica Kam Damdimopoulou, Pauliina O’Brien, Jason M |
author_sort | Svingen, Terje |
collection | PubMed |
description | The adverse outcome pathway (AOP) framework provides a practical means for organizing scientific knowledge that can be used to infer cause-effect relationships between stressor events and toxicity outcomes in intact organisms. It has reached wide acceptance as a tool to aid chemical safety assessment and regulatory toxicology by supporting a systematic way of predicting adverse health outcomes based on accumulated mechanistic knowledge. A major challenge for broader application of the AOP concept in regulatory toxicology, however, has been developing robust AOPs to a level where they are peer reviewed and accepted. This is because the amount of work required to substantiate the modular units of a complete AOP is considerable, to the point where it can take years from start to finish. To help alleviate this bottleneck, we propose a more pragmatic approach to AOP development whereby the focus becomes on smaller blocks. First, we argue that the key event relationship (KER) should be formally recognized as the core building block of knowledge assembly within the AOP knowledge base (AOP-KB), albeit framing them within full AOPs to ensure regulatory utility. Second, we argue that KERs should be developed using systematic review approaches, but only in cases where the underlying concept does not build on what is considered canonical knowledge. In cases where knowledge is considered canonical, rigorous systematic review approaches should not be required. It is our hope that these approaches will contribute to increasing the pace at which the AOP-KB is populated with AOPs with utility for chemical safety assessors and regulators. |
format | Online Article Text |
id | pubmed-8633887 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-86338872021-12-01 A Pragmatic Approach to Adverse Outcome Pathway Development and Evaluation Svingen, Terje Villeneuve, Daniel L Knapen, Dries Panagiotou, Eleftheria Maria Draskau, Monica Kam Damdimopoulou, Pauliina O’Brien, Jason M Toxicol Sci Forum The adverse outcome pathway (AOP) framework provides a practical means for organizing scientific knowledge that can be used to infer cause-effect relationships between stressor events and toxicity outcomes in intact organisms. It has reached wide acceptance as a tool to aid chemical safety assessment and regulatory toxicology by supporting a systematic way of predicting adverse health outcomes based on accumulated mechanistic knowledge. A major challenge for broader application of the AOP concept in regulatory toxicology, however, has been developing robust AOPs to a level where they are peer reviewed and accepted. This is because the amount of work required to substantiate the modular units of a complete AOP is considerable, to the point where it can take years from start to finish. To help alleviate this bottleneck, we propose a more pragmatic approach to AOP development whereby the focus becomes on smaller blocks. First, we argue that the key event relationship (KER) should be formally recognized as the core building block of knowledge assembly within the AOP knowledge base (AOP-KB), albeit framing them within full AOPs to ensure regulatory utility. Second, we argue that KERs should be developed using systematic review approaches, but only in cases where the underlying concept does not build on what is considered canonical knowledge. In cases where knowledge is considered canonical, rigorous systematic review approaches should not be required. It is our hope that these approaches will contribute to increasing the pace at which the AOP-KB is populated with AOPs with utility for chemical safety assessors and regulators. Oxford University Press 2021-09-17 /pmc/articles/PMC8633887/ /pubmed/34534351 http://dx.doi.org/10.1093/toxsci/kfab113 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Society of Toxicology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Forum Svingen, Terje Villeneuve, Daniel L Knapen, Dries Panagiotou, Eleftheria Maria Draskau, Monica Kam Damdimopoulou, Pauliina O’Brien, Jason M A Pragmatic Approach to Adverse Outcome Pathway Development and Evaluation |
title | A Pragmatic Approach to Adverse Outcome Pathway Development and Evaluation |
title_full | A Pragmatic Approach to Adverse Outcome Pathway Development and Evaluation |
title_fullStr | A Pragmatic Approach to Adverse Outcome Pathway Development and Evaluation |
title_full_unstemmed | A Pragmatic Approach to Adverse Outcome Pathway Development and Evaluation |
title_short | A Pragmatic Approach to Adverse Outcome Pathway Development and Evaluation |
title_sort | pragmatic approach to adverse outcome pathway development and evaluation |
topic | Forum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633887/ https://www.ncbi.nlm.nih.gov/pubmed/34534351 http://dx.doi.org/10.1093/toxsci/kfab113 |
work_keys_str_mv | AT svingenterje apragmaticapproachtoadverseoutcomepathwaydevelopmentandevaluation AT villeneuvedaniell apragmaticapproachtoadverseoutcomepathwaydevelopmentandevaluation AT knapendries apragmaticapproachtoadverseoutcomepathwaydevelopmentandevaluation AT panagiotoueleftheriamaria apragmaticapproachtoadverseoutcomepathwaydevelopmentandevaluation AT draskaumonicakam apragmaticapproachtoadverseoutcomepathwaydevelopmentandevaluation AT damdimopouloupauliina apragmaticapproachtoadverseoutcomepathwaydevelopmentandevaluation AT obrienjasonm apragmaticapproachtoadverseoutcomepathwaydevelopmentandevaluation AT svingenterje pragmaticapproachtoadverseoutcomepathwaydevelopmentandevaluation AT villeneuvedaniell pragmaticapproachtoadverseoutcomepathwaydevelopmentandevaluation AT knapendries pragmaticapproachtoadverseoutcomepathwaydevelopmentandevaluation AT panagiotoueleftheriamaria pragmaticapproachtoadverseoutcomepathwaydevelopmentandevaluation AT draskaumonicakam pragmaticapproachtoadverseoutcomepathwaydevelopmentandevaluation AT damdimopouloupauliina pragmaticapproachtoadverseoutcomepathwaydevelopmentandevaluation AT obrienjasonm pragmaticapproachtoadverseoutcomepathwaydevelopmentandevaluation |